Table 5. Correlation of FABP4 and clinical parameters.
| non-DM | T2DM | |||
|---|---|---|---|---|
| r | p | r | P | |
| IRI(120)(pmol/L) | 0.225 | 0.369 | 0.604 | 0.038* |
| Insulinogenic Index | 0.536 | 0.022* | 0.359 | 0.252 |
| BMI | 0.441 | 0.667 | 0.309 | 0.328 |
| hs-CRP | 0.255 | 0.306 | 0.314 | 0.320 |
| TG | 0.406 | 0.094 | 0.059 | 0.856 |
| FPG | 0.004 | 0.986 | 0.204 | 0.525 |
| fasting CPR | 0.453 | 0.059 | 0.570 | 0.053 |
| fasting IRI (pmol/L) | 0.435 | 0.071 | 0.441 | 0.151 |
| CPR-IR | -0.263 | 0.293 | -0.507 | 0.093 |
| HOMA-R | 0.419 | 0.084 | 0.449 | 0.143 |
| AUC120(Glu) | 0.100 | 0.693 | 0.233 | 0.466 |
| AUC120(IRI) | 0.331 | 0.180 | 0.508 | 0.092 |
Correlation coefficients were determined using Pearson’s product moment correlation coefficient test. CPR-IR, C-peptide immunoreactivity insulin resistance. IRI (120), IRI at 120 minutes in MTT.